Cancer vaccine prolongs remission in leukemia patients in tr
A new vaccine helped leukemia patients fight their cancer and stay in remission for an average of almost five years, according to new study.

Patients who had undergone chemotherapy to treat acute myeloid leukemia received vaccines personalized to their own form of the disease, to stimulate a potent immune attack against it and reduce the likelihood of their cancer returning.

For the trial, people over the age of 60 were particularly targeted, as only 15% to 20% of this age group remains leukemia-free for two years, on average, after receiving chemotherapy....